Special Edition Q3, 2022 Feature Events Education & Training The VivoWay News References Feature 66% of Diagnostic Biopsies for Common Skin Cancer can be Avoided

Join us for our March 2022 issue of VivoScene!:

• Feature: VivoSight OCT Increasingly Utilized in Nail
Disease Research
• Latest News: Two Seminal Recent Articles Confirm Value
of OCT for Basal Cell Carcinoma
• The VivoWay: Elevator Chat with Christine Fuchs
Jacobsen, MD, PhD – Copenhagen, Denmark

Additional content on: Education & Training – News & Events

Join us for our November 2021 issue of VivoScene!:

• Feature: Latest State-of-the-Art Skin Imaging Technologies at Mount Sinai Dept. of Dermatology
• News: New study by Orit Markowitz, MD and Cynthia Chan, MD on Early Success Indication of Lengthy Onychomycosis Treatment through OCT Biomarkers.
• The VivoWay: Elevator Chat with Johann Tillmann, CEO of DermoScan

Additional content on: Education & Training – News & Events

Join us for our Sept 2021 issue of VivoScene!:

• Latest News: Video Blog by MDL CEO Jon Holmes on recent Markowitz et al. paper: 98% Clearance at 1 Year withNonsurgical In-office Treatment of Basal Cell Carcinoma(BCC).
• Feature: Merete Haedersdal, MD, PhD – On a Mission to Accelerate Discoveries and Modernize Clinical Practice.
• The VivoWay: Elevator Chat with Giovanni Pellacani, MD

Additional content on: Education & Training – News & Events

Join us for our July 2021 issue of VivoScene!:

• Latest News: Innovaderm acquires VivoSight OCT System
• Feature: Adding Artificial Intelligence (AI) to Delineate Basal Cell Carcinoma (BCC)
• The VivoWay: Elevator Chat with Barry DiBernardo, MD

Additional content on: Education & Training – News & Events – Product Updates. Read more >